- LivaNova (NASDAQ:LIVN) has completed its acquisition of privately held TandemLife for $200M in cash plus up to an additional $50M in regulatory milestones.
- TandemLife develops advanced cardiopulmonary temporary support solutions. LIvaNova says the deal will be modestly accretive this year.